Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Jeannette Lee

Concepts (468)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
22
2023
394
2.960
 Why?
Anus Neoplasms
10
2023
26
2.030
 Why?
Stroke
8
2024
527
1.850
 Why?
Acquired Immunodeficiency Syndrome
11
2022
53
1.530
 Why?
Prostatic Hyperplasia
10
2015
39
1.370
 Why?
Brain
10
2024
1337
1.350
 Why?
Parkinson Disease
2
2023
168
1.190
 Why?
Randomized Controlled Trials as Topic
8
2024
625
1.160
 Why?
Chlamydia Infections
8
2017
74
1.160
 Why?
Papillomavirus Infections
6
2022
170
1.110
 Why?
Mesenchymal Stem Cell Transplantation
2
2024
23
1.030
 Why?
Sarcoma, Kaposi
12
2022
76
1.010
 Why?
Chlamydia trachomatis
6
2017
29
0.970
 Why?
Lymphoma, AIDS-Related
10
2020
16
0.940
 Why?
Brain Ischemia
2
2023
168
0.860
 Why?
Plant Extracts
5
2013
199
0.850
 Why?
Humans
102
2025
52441
0.830
 Why?
Serenoa
5
2013
7
0.820
 Why?
Phytotherapy
3
2012
45
0.760
 Why?
Rural Population
4
2023
587
0.760
 Why?
Umbilical Cord
2
2020
36
0.750
 Why?
Antineoplastic Combined Chemotherapy Protocols
12
2021
1020
0.690
 Why?
Lymphoma, Non-Hodgkin
6
2021
58
0.690
 Why?
Middle Aged
50
2021
13133
0.680
 Why?
Research Design
5
2022
368
0.650
 Why?
Fetal Blood
2
2019
78
0.620
 Why?
Adult
50
2022
14205
0.620
 Why?
Male
58
2024
26874
0.600
 Why?
Inflammation
3
2021
649
0.590
 Why?
Patient Participation
1
2018
65
0.560
 Why?
Rats
9
2024
3228
0.560
 Why?
Vaginosis, Bacterial
2
2015
8
0.530
 Why?
Decision Making
1
2018
273
0.500
 Why?
Antineoplastic Agents
10
2023
1216
0.490
 Why?
Neoplasms
3
2023
1314
0.490
 Why?
Mammography
1
2016
97
0.490
 Why?
Stem Cells
3
2025
186
0.480
 Why?
Female
46
2024
28277
0.460
 Why?
Antibodies, Monoclonal, Murine-Derived
6
2015
46
0.460
 Why?
Aged
28
2020
10242
0.450
 Why?
Infarction, Middle Cerebral Artery
3
2024
42
0.450
 Why?
Population Density
1
2014
16
0.440
 Why?
Pelvic Inflammatory Disease
2
2018
7
0.440
 Why?
AIDS-Related Opportunistic Infections
5
2016
38
0.440
 Why?
Stem Cell Transplantation
4
2025
188
0.430
 Why?
Carcinoma in Situ
3
2013
72
0.430
 Why?
Cytokines
5
2023
622
0.420
 Why?
Animals
14
2025
13485
0.410
 Why?
Neonatal Abstinence Syndrome
2
2024
23
0.410
 Why?
Uterine Cervicitis
1
2013
3
0.410
 Why?
Anti-Bacterial Agents
5
2020
816
0.400
 Why?
Urethritis
2
2012
5
0.390
 Why?
Hydrocephalus, Normal Pressure
1
2012
2
0.390
 Why?
Lymphoma, Large B-Cell, Diffuse
3
2021
108
0.380
 Why?
Finasteride
4
2015
4
0.380
 Why?
Research Subjects
1
2013
53
0.380
 Why?
Guideline Adherence
1
2013
142
0.380
 Why?
Breast Neoplasms
3
2017
1203
0.370
 Why?
Rats, Sprague-Dawley
5
2024
1558
0.370
 Why?
Subarachnoid Hemorrhage
1
2012
62
0.370
 Why?
Patient Dropouts
1
2012
52
0.360
 Why?
Carcinoma, Non-Small-Cell Lung
1
2013
177
0.350
 Why?
Urologic Diseases
1
2011
9
0.350
 Why?
Homosexuality, Male
4
2022
54
0.350
 Why?
HIV-1
6
2020
60
0.340
 Why?
Lung Neoplasms
2
2013
643
0.330
 Why?
Disease Models, Animal
5
2024
1483
0.330
 Why?
Young Adult
17
2019
4346
0.330
 Why?
United States
10
2023
5215
0.320
 Why?
Papillomaviridae
3
2019
102
0.320
 Why?
Patient Selection
1
2011
269
0.310
 Why?
Quality of Life
6
2024
893
0.310
 Why?
Lymphedema
2
2022
47
0.310
 Why?
Analgesics, Opioid
3
2024
601
0.300
 Why?
HIV Seropositivity
3
2021
28
0.300
 Why?
Lower Urinary Tract Symptoms
3
2013
7
0.300
 Why?
Intestinal Mucosa
2
2021
228
0.300
 Why?
Asthma
2
2024
313
0.300
 Why?
Polymorphism, Single Nucleotide
3
2017
506
0.290
 Why?
Gonorrhea
2
2020
9
0.280
 Why?
Azithromycin
4
2020
25
0.280
 Why?
Uterine Cervical Neoplasms
2
2022
299
0.280
 Why?
Anal Canal
4
2023
27
0.270
 Why?
Th1 Cells
2
2017
51
0.260
 Why?
Prospective Studies
12
2022
2433
0.260
 Why?
Risk Factors
8
2022
3971
0.260
 Why?
Vascular Endothelial Growth Factor A
4
2017
186
0.250
 Why?
Mycoplasma genitalium
2
2018
2
0.240
 Why?
Doxazosin
3
2015
3
0.240
 Why?
Prevalence
7
2021
1016
0.240
 Why?
Mycoplasma Infections
2
2018
7
0.240
 Why?
Treatment Outcome
16
2020
5508
0.240
 Why?
Doxycycline
3
2015
33
0.240
 Why?
Cyclophosphamide
9
2021
176
0.230
 Why?
Cancer Vaccines
1
2006
78
0.230
 Why?
Anti-Infective Agents
2
2020
106
0.230
 Why?
Adolescent
13
2022
6713
0.230
 Why?
Vincristine
8
2021
89
0.230
 Why?
Multicenter Studies as Topic
4
2024
112
0.230
 Why?
Hematopoietic Stem Cell Transplantation
3
2018
600
0.220
 Why?
Circadian Rhythm
1
2025
92
0.220
 Why?
Air Filters
1
2024
1
0.220
 Why?
Double-Blind Method
4
2013
726
0.210
 Why?
CD4 Lymphocyte Count
7
2020
33
0.210
 Why?
Bronchiolitis
1
2024
28
0.210
 Why?
Air Pollution, Indoor
1
2024
27
0.210
 Why?
5-alpha Reductase Inhibitors
2
2015
4
0.210
 Why?
Hyperbaric Oxygenation
1
2023
15
0.210
 Why?
Cell Differentiation
3
2025
667
0.210
 Why?
Neoplasm Staging
5
2022
768
0.210
 Why?
Substantia Nigra
1
2023
14
0.200
 Why?
alpha-Synuclein
1
2023
11
0.200
 Why?
Doxorubicin
8
2021
246
0.200
 Why?
Cisplatin
3
2022
282
0.200
 Why?
Transplantation Conditioning
2
2018
93
0.200
 Why?
Tumor Necrosis Factor-alpha
2
2017
390
0.200
 Why?
Informatics
1
2023
9
0.200
 Why?
Herpesvirus 8, Human
5
2020
97
0.200
 Why?
Prednisone
7
2021
100
0.200
 Why?
Follow-Up Studies
8
2019
2294
0.190
 Why?
Cross-Sectional Studies
3
2021
1677
0.190
 Why?
Astrocytes
1
2024
148
0.190
 Why?
Brachytherapy
1
2022
50
0.190
 Why?
Neuroprotective Agents
2
2020
103
0.190
 Why?
Watchful Waiting
1
2022
29
0.190
 Why?
Oxidative Phosphorylation
1
2022
46
0.190
 Why?
Medical Records
1
2022
83
0.190
 Why?
Feasibility Studies
2
2021
404
0.190
 Why?
Absorptiometry, Photon
1
2003
161
0.190
 Why?
Vitamin D Deficiency
1
2022
41
0.180
 Why?
Substance Withdrawal Syndrome
1
2023
168
0.180
 Why?
Brain Injuries
1
2023
158
0.180
 Why?
Vaccines
1
2022
47
0.180
 Why?
Viral Load
6
2020
81
0.180
 Why?
Genome-Wide Association Study
3
2018
184
0.180
 Why?
Child
7
2024
7194
0.180
 Why?
Case-Control Studies
3
2014
1202
0.180
 Why?
Clinical Trials as Topic
5
2020
461
0.180
 Why?
Precancerous Conditions
1
2022
87
0.180
 Why?
Lymphocyte Activation
3
2017
161
0.180
 Why?
Mouth Diseases
1
2021
5
0.180
 Why?
Mass Screening
2
2015
354
0.180
 Why?
Vaccination
3
2022
294
0.180
 Why?
Thymus Gland
1
2021
40
0.180
 Why?
Pluripotent Stem Cells
1
2021
8
0.170
 Why?
Progestins
1
2020
13
0.170
 Why?
Primary Health Care
2
2022
387
0.170
 Why?
Physical Conditioning, Animal
1
2021
64
0.170
 Why?
T-Lymphocyte Subsets
2
2017
40
0.170
 Why?
Drug Therapy, Combination
5
2015
404
0.170
 Why?
Papillomavirus Vaccines
2
2013
69
0.170
 Why?
Vagina
2
2018
46
0.170
 Why?
Etoposide
5
2021
70
0.170
 Why?
Spleen
1
2021
166
0.170
 Why?
Enzyme Inhibitors
2
2016
378
0.170
 Why?
Cross-Over Studies
1
2021
236
0.170
 Why?
Anti-HIV Agents
3
2020
46
0.170
 Why?
Genes, myc
1
2020
39
0.160
 Why?
Gene Frequency
2
2017
97
0.160
 Why?
Overweight
1
2022
230
0.160
 Why?
Transplantation, Autologous
3
2018
479
0.160
 Why?
Aged, 80 and over
5
2013
3449
0.160
 Why?
Nervous System Diseases
1
2020
96
0.150
 Why?
Dihydroxyphenylalanine
1
2019
5
0.150
 Why?
Dopaminergic Neurons
1
2019
19
0.150
 Why?
Ablation Techniques
1
2019
19
0.150
 Why?
Genitalia, Male
1
2019
16
0.150
 Why?
Altruism
1
2018
12
0.150
 Why?
Sodium, Dietary
1
2019
24
0.150
 Why?
Central Nervous System Diseases
1
2019
25
0.150
 Why?
Mouth
1
2019
33
0.150
 Why?
Asymptomatic Infections
1
2018
6
0.140
 Why?
Mitochondria
2
2020
420
0.140
 Why?
Dopamine
1
2019
170
0.140
 Why?
Antiviral Agents
2
2013
173
0.140
 Why?
Sexually Transmitted Diseases
1
2018
36
0.140
 Why?
Encephalitis
1
2018
39
0.140
 Why?
Hyperthermia, Induced
1
2019
114
0.140
 Why?
Chlamydia
1
2017
7
0.140
 Why?
Energy Metabolism
1
2020
315
0.140
 Why?
Regeneration
1
2018
79
0.140
 Why?
Mucous Membrane
1
2017
33
0.140
 Why?
Exosomes
1
2018
56
0.140
 Why?
Blood Cells
1
2017
37
0.140
 Why?
Biopsy
2
2022
594
0.140
 Why?
Pilot Projects
3
2019
725
0.130
 Why?
Genetic Predisposition to Disease
2
2018
525
0.130
 Why?
Protein Kinase Inhibitors
2
2023
231
0.130
 Why?
DNA, Circular
1
2017
17
0.130
 Why?
Clostridium Infections
1
2018
55
0.130
 Why?
Antibodies, Bacterial
1
2017
29
0.130
 Why?
Clonal Evolution
1
2017
57
0.130
 Why?
Immunoglobulins
1
2017
76
0.130
 Why?
Immunoglobulin G
1
2017
193
0.130
 Why?
Enzyme-Linked Immunosorbent Assay
2
2017
234
0.130
 Why?
Anus Diseases
1
2016
2
0.120
 Why?
Sentinel Lymph Node Biopsy
1
2017
119
0.120
 Why?
Telemedicine
1
2022
490
0.120
 Why?
Lymph Node Excision
1
2017
133
0.120
 Why?
Mannitol
1
2016
14
0.120
 Why?
Guidelines as Topic
1
2016
111
0.120
 Why?
Thiazoles
1
2016
53
0.120
 Why?
Adrenergic alpha-1 Receptor Antagonists
1
2015
7
0.120
 Why?
Diagnostic Self Evaluation
1
2015
13
0.120
 Why?
Blood-Brain Barrier
1
2016
50
0.120
 Why?
Dose-Response Relationship, Drug
4
2013
1365
0.120
 Why?
CD4-Positive T-Lymphocytes
1
2017
165
0.120
 Why?
T-Lymphocytes
1
2017
318
0.120
 Why?
Infant, Newborn
4
2024
2871
0.120
 Why?
Educational Status
1
2016
227
0.120
 Why?
Tinidazole
2
2012
2
0.120
 Why?
Imidazoles
1
2016
114
0.120
 Why?
Time Factors
6
2023
2987
0.120
 Why?
Burkitt Lymphoma
1
2015
27
0.120
 Why?
Lymph Nodes
1
2017
253
0.110
 Why?
Drug Administration Schedule
5
2020
370
0.110
 Why?
Menarche
1
2014
7
0.110
 Why?
Data Collection
3
2023
285
0.110
 Why?
Chromosomes, Human, Pair 2
1
2014
25
0.110
 Why?
Obesity
3
2022
1176
0.110
 Why?
Stomatitis
1
2014
20
0.110
 Why?
Immunophenotyping
2
2017
115
0.110
 Why?
Disease-Free Survival
5
2016
461
0.110
 Why?
Hypogonadism
1
2013
13
0.100
 Why?
Benzamides
1
2013
52
0.100
 Why?
Carcinoma, Squamous Cell
1
2016
331
0.100
 Why?
Incidence
4
2018
1096
0.100
 Why?
Health Surveys
1
2014
238
0.100
 Why?
Urban Population
1
2014
161
0.100
 Why?
SEER Program
1
2013
105
0.100
 Why?
Regenerative Medicine
2
2025
12
0.100
 Why?
Organophosphonates
1
2013
6
0.100
 Why?
Perineum
1
2013
26
0.100
 Why?
DNA, Viral
3
2020
134
0.100
 Why?
Heart Failure
1
2019
527
0.100
 Why?
Placebos
1
2013
83
0.100
 Why?
Testosterone
1
2013
145
0.100
 Why?
Cytosine
1
2013
30
0.100
 Why?
Adrenergic alpha-Antagonists
2
2009
27
0.100
 Why?
Piperazines
1
2013
125
0.100
 Why?
tau Proteins
1
2012
31
0.100
 Why?
Prostate
2
2015
116
0.100
 Why?
Trichomonas Infections
1
2012
2
0.100
 Why?
Trichomonas vaginalis
1
2012
2
0.100
 Why?
HIV
3
2023
26
0.100
 Why?
Transforming Growth Factor beta1
1
2012
61
0.100
 Why?
Pyrimidines
1
2013
199
0.090
 Why?
Sleep
2
2024
191
0.090
 Why?
Vulvar Neoplasms
1
2013
60
0.090
 Why?
Urination Disorders
1
2011
23
0.090
 Why?
Androgen Antagonists
1
2011
12
0.090
 Why?
Medicare
1
2013
281
0.090
 Why?
Comorbidity
1
2013
637
0.090
 Why?
Sirolimus
1
2012
72
0.090
 Why?
CD8-Positive T-Lymphocytes
2
2017
140
0.090
 Why?
Kenya
2
2022
11
0.090
 Why?
Antibiotics, Antineoplastic
1
2012
83
0.090
 Why?
Quinazolinones
1
2011
7
0.090
 Why?
Human papillomavirus 16
2
2013
44
0.080
 Why?
Arkansas
1
2016
2013
0.080
 Why?
Practice Guidelines as Topic
1
2013
498
0.080
 Why?
Social Class
1
2011
97
0.080
 Why?
Multivariate Analysis
1
2012
601
0.080
 Why?
Chronic Disease
1
2012
579
0.080
 Why?
Prognosis
5
2017
2100
0.080
 Why?
Piperidines
1
2011
99
0.080
 Why?
Plant Bark
1
2009
4
0.080
 Why?
Multiple Myeloma
2
2014
3013
0.080
 Why?
Valproic Acid
1
2009
35
0.080
 Why?
Ki-67 Antigen
1
2009
57
0.080
 Why?
Colorectal Neoplasms
1
2013
286
0.080
 Why?
Socioeconomic Factors
1
2012
609
0.080
 Why?
Logistic Models
1
2012
930
0.080
 Why?
India
2
2021
60
0.070
 Why?
Fruit
1
2009
130
0.070
 Why?
Tetracyclines
2
2006
9
0.070
 Why?
Neoplasm Recurrence, Local
1
2012
639
0.070
 Why?
Survival Analysis
3
2017
656
0.070
 Why?
Antiretroviral Therapy, Highly Active
3
2015
32
0.070
 Why?
Glioblastoma
1
2009
89
0.070
 Why?
Adaptive Immunity
2
2017
34
0.070
 Why?
Chemoradiotherapy
2
2019
50
0.070
 Why?
Sexual Partners
2
2018
40
0.070
 Why?
Stress, Psychological
1
2009
275
0.060
 Why?
Disease Progression
4
2013
870
0.060
 Why?
Regression Analysis
2
2018
400
0.060
 Why?
Chaperonins
1
2006
3
0.060
 Why?
Chaperonin 60
1
2006
6
0.060
 Why?
Dose-Response Relationship, Immunologic
1
2006
13
0.060
 Why?
Lymphocyte Count
1
2006
20
0.060
 Why?
Papillomavirus E7 Proteins
1
2006
30
0.060
 Why?
Immunohistochemistry
3
2017
977
0.060
 Why?
Sexual Behavior
2
2018
127
0.060
 Why?
Viral Vaccines
1
2006
16
0.060
 Why?
HIV Protease Inhibitors
1
2006
3
0.060
 Why?
Interferon-alpha
1
2006
52
0.060
 Why?
Nephrosis, Lipoid
1
2005
7
0.060
 Why?
Arterioles
1
2005
33
0.060
 Why?
Body Mass Index
2
2022
701
0.060
 Why?
Recombinant Fusion Proteins
1
2006
177
0.060
 Why?
Severity of Illness Index
2
2023
1045
0.060
 Why?
Brain Neoplasms
1
2009
302
0.060
 Why?
Circadian Clocks
1
2025
3
0.060
 Why?
Matrix Metalloproteinase 9
3
2017
88
0.060
 Why?
Administration, Oral
4
2013
455
0.060
 Why?
Administration, Intranasal
1
2024
30
0.060
 Why?
Phenotype
2
2017
792
0.060
 Why?
Anti-Retroviral Agents
2
2019
19
0.050
 Why?
Neutropenia
2
2020
113
0.050
 Why?
Genotype
2
2017
563
0.050
 Why?
Confidence Intervals
2
2015
158
0.050
 Why?
Dust
1
2024
24
0.050
 Why?
Particulate Matter
1
2024
70
0.050
 Why?
Carbon
1
2024
60
0.050
 Why?
Cytochrome P-450 CYP3A
1
2023
78
0.050
 Why?
Femur Neck
1
2003
6
0.050
 Why?
Africa South of the Sahara
1
2022
6
0.050
 Why?
Bacterial Proteins
1
2006
347
0.050
 Why?
Hip
1
2003
23
0.050
 Why?
Oligomycins
1
2022
8
0.050
 Why?
Rotenone
1
2022
13
0.050
 Why?
Galactose
1
2022
29
0.050
 Why?
Narcotics
1
2023
109
0.050
 Why?
Quality Control
1
2003
98
0.050
 Why?
Sample Size
1
2022
50
0.050
 Why?
Eating
1
2023
158
0.050
 Why?
Vitamins
1
2022
59
0.050
 Why?
Femur
1
2003
132
0.050
 Why?
Spine
1
2003
86
0.050
 Why?
Glycolysis
1
2022
70
0.050
 Why?
Matrix Metalloproteinase Inhibitors
1
2002
9
0.050
 Why?
Tetracycline
1
2002
24
0.050
 Why?
Vitamin D
1
2022
86
0.050
 Why?
Radiotherapy Dosage
1
2022
256
0.050
 Why?
Sodium
1
2022
92
0.050
 Why?
Tretinoin
1
2002
53
0.040
 Why?
Leg
1
2022
122
0.040
 Why?
Fibroblast Growth Factor 2
2
2017
35
0.040
 Why?
Antibodies, Monoclonal
1
2005
475
0.040
 Why?
Museums
1
2021
2
0.040
 Why?
Ischemia
1
2022
150
0.040
 Why?
Alprostadil
1
2021
9
0.040
 Why?
Progesterone
1
2020
60
0.040
 Why?
Oxygen
1
2023
332
0.040
 Why?
Kidney
1
2005
716
0.040
 Why?
Length of Stay
1
2024
673
0.040
 Why?
Zimbabwe
1
2020
3
0.040
 Why?
Receptors, Progesterone
1
2020
68
0.040
 Why?
Malawi
1
2020
15
0.040
 Why?
Wharton Jelly
1
2020
2
0.040
 Why?
Uganda
1
2020
38
0.040
 Why?
Software
1
2003
281
0.040
 Why?
Spinal Cord Injuries
1
2020
55
0.040
 Why?
Cell Shape
1
2020
21
0.040
 Why?
Herpesvirus 4, Human
1
2020
43
0.040
 Why?
Body Composition
1
2003
343
0.040
 Why?
Neisseria gonorrhoeae
1
2020
4
0.040
 Why?
Glucose
1
2022
356
0.040
 Why?
Herpesviridae Infections
1
2020
57
0.040
 Why?
Ceftriaxone
1
2020
24
0.040
 Why?
Histone Deacetylase Inhibitors
1
2020
57
0.040
 Why?
B-Lymphocytes
1
2021
178
0.040
 Why?
Drug Resistance, Bacterial
1
2020
75
0.040
 Why?
Thrombocytopenia
1
2020
93
0.040
 Why?
Interleukin-6
2
2016
271
0.040
 Why?
Remission Induction
2
2012
218
0.040
 Why?
Proctoscopy
1
2019
2
0.040
 Why?
Kaplan-Meier Estimate
1
2020
485
0.040
 Why?
Microbial Sensitivity Tests
1
2020
271
0.040
 Why?
Radiation-Sensitizing Agents
1
2019
50
0.040
 Why?
Forelimb
1
2018
4
0.040
 Why?
Cell Survival
1
2020
598
0.040
 Why?
Green Fluorescent Proteins
1
2018
85
0.040
 Why?
Models, Animal
1
2019
230
0.040
 Why?
Rats, Inbred F344
1
2018
194
0.040
 Why?
Statistics, Nonparametric
2
2013
199
0.040
 Why?
Receptors, Chemokine
1
2017
13
0.040
 Why?
Cluster Analysis
1
2018
236
0.030
 Why?
Pandemics
1
2022
580
0.030
 Why?
Coinfection
1
2018
41
0.030
 Why?
Bone Marrow
1
2019
354
0.030
 Why?
Postural Balance
1
2018
59
0.030
 Why?
Neurodegenerative Diseases
1
2019
83
0.030
 Why?
Neurogenesis
1
2017
27
0.030
 Why?
Cell Separation
1
2017
78
0.030
 Why?
Muscle Strength
1
2018
132
0.030
 Why?
Cytological Techniques
1
2017
13
0.030
 Why?
Angiopoietin-2
1
2017
14
0.030
 Why?
Interleukin-2
1
2017
69
0.030
 Why?
Angiopoietin-1
1
2017
16
0.030
 Why?
Receptor, TIE-2
1
2017
16
0.030
 Why?
Axilla
1
2017
92
0.030
 Why?
Clinical Trials, Phase II as Topic
1
2017
48
0.030
 Why?
Staining and Labeling
1
2017
92
0.030
 Why?
Fluorouracil
1
2016
56
0.030
 Why?
Gene Rearrangement
1
2017
76
0.030
 Why?
Biopsy, Needle
1
2017
181
0.030
 Why?
Odds Ratio
1
2018
563
0.030
 Why?
Membrane Glycoproteins
1
2017
239
0.030
 Why?
Interferon-gamma
1
2017
169
0.030
 Why?
Mastectomy
1
2017
145
0.030
 Why?
Cord Blood Stem Cell Transplantation
1
2016
9
0.030
 Why?
Directly Observed Therapy
1
2015
5
0.030
 Why?
Urine
1
2015
26
0.030
 Why?
Reagent Kits, Diagnostic
1
2015
17
0.030
 Why?
Vaginal Smears
1
2015
28
0.030
 Why?
Flow Cytometry
1
2017
396
0.030
 Why?
Neovascularization, Pathologic
1
2017
158
0.030
 Why?
RNA, Viral
2
2009
123
0.030
 Why?
Neoadjuvant Therapy
1
2017
124
0.030
 Why?
Prisons
1
2015
37
0.030
 Why?
Treatment Failure
1
2015
117
0.030
 Why?
Ifosfamide
1
2015
8
0.030
 Why?
Infant
1
2024
3709
0.030
 Why?
Cytarabine
1
2015
42
0.030
 Why?
Magnetic Resonance Imaging
1
2022
1507
0.030
 Why?
Methotrexate
1
2015
76
0.030
 Why?
Induction Chemotherapy
1
2014
65
0.030
 Why?
Receptor, Platelet-Derived Growth Factor beta
1
2013
18
0.030
 Why?
Matrix Metalloproteinase 2
2
2006
59
0.030
 Why?
Proto-Oncogene Proteins c-kit
1
2013
33
0.030
 Why?
Depression
1
2019
603
0.030
 Why?
Melphalan
1
2014
176
0.030
 Why?
Cohort Studies
1
2018
1576
0.030
 Why?
Statistics as Topic
1
2013
89
0.030
 Why?
Cancer Care Facilities
1
2013
20
0.020
 Why?
Time
1
2013
29
0.020
 Why?
Administration, Cutaneous
1
2013
53
0.020
 Why?
Gene Expression Regulation
1
2017
1004
0.020
 Why?
Infusions, Intravenous
1
2013
212
0.020
 Why?
Specialization
1
2013
48
0.020
 Why?
Demography
1
2013
92
0.020
 Why?
Molecular Targeted Therapy
1
2013
135
0.020
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2013
62
0.020
 Why?
Combined Modality Therapy
1
2014
641
0.020
 Why?
Antitrichomonal Agents
1
2012
1
0.020
 Why?
Reference Values
1
2013
316
0.020
 Why?
Risk Assessment
1
2017
1349
0.020
 Why?
Polyethylene Glycols
1
2012
93
0.020
 Why?
Medical Oncology
1
2013
97
0.020
 Why?
Antigens, Viral
1
2012
44
0.020
 Why?
Administration, Topical
1
2011
62
0.020
 Why?
Single-Blind Method
1
2011
118
0.020
 Why?
Neoplasm Proteins
1
2013
328
0.020
 Why?
Organ Size
1
2011
226
0.020
 Why?
Sex Factors
1
2013
735
0.020
 Why?
Retrospective Studies
1
2022
6694
0.020
 Why?
Survival Rate
1
2012
944
0.020
 Why?
Antibodies, Viral
1
2010
113
0.020
 Why?
Psychiatric Status Rating Scales
1
2009
324
0.020
 Why?
Mutation
1
2013
1331
0.020
 Why?
Busulfan
1
2008
18
0.020
 Why?
Psychometrics
1
2009
238
0.020
 Why?
Mice
1
2017
5899
0.020
 Why?
Ultrasonography
1
2008
416
0.020
 Why?
Maximum Tolerated Dose
1
2006
39
0.020
 Why?
Injections, Subcutaneous
1
2006
54
0.020
 Why?
Hypertension, Renal
1
2005
21
0.010
 Why?
Cell Proliferation
1
2009
1013
0.010
 Why?
Fatigue
1
2006
126
0.010
 Why?
Recombinant Proteins
1
2006
490
0.010
 Why?
Receptors, Interleukin-6
1
2002
22
0.010
 Why?
Endothelial Growth Factors
1
2002
11
0.010
 Why?
Vascular Endothelial Growth Factors
1
2002
15
0.010
 Why?
Lymphokines
1
2002
20
0.010
 Why?
Drug Tolerance
1
2002
60
0.010
 Why?
Safety
1
2002
78
0.010
 Why?
Child, Preschool
1
2005
4046
0.010
 Why?
Lee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (468) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (28) people
_
Same Department Expand Description
Search Department